Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke

Open access
Meretoja, Atte, Putaala, Jukka, Tatlisumak, Turgut, Atula, Sari, Artto, Ville, Curtze, Sami, Häppölä, Olli, Lindsberg, Perttu J., Mustanoja, Satu, Piironen, Katja, Pitkäniemi, Janne, Rantanen, Kirsi, Sairanen, Tiina, Salonen, Oili, Silvennoinen, Heli, Soinne, Lauri, Strbian, Daniel, Tiainen, Marjaana, Kaste, Markku·2010·Stroke

Abstract

Background and Purpose— Numerous contraindications included in the license of alteplase, most of which are not based on scientific evidence, restrict the portion of patients with acute ischemic stroke eligible for treatment with alteplase. We studied whether off-label thrombolysis was associated with poorer outcome or increased rates of symptomatic intracerebral hemorrhage compared with on-label use. Methods— All consecutive patients with stroke treated with intravenous thrombolysis from 1995 to 2008 at the Helsinki University Central Hospital were registered (n=1104). After excluding basilar artery occlusions (n=119), the study population included 985 patients. Clinical outcome (modified Rankin Scale 0 to 2 versus 3 to 6) and symptomatic intracerebral hemorrhage according to 3 earlier published criteria were analyzed with a logistic regression model adjusting for 21 baseline variables. Results— One or more license contraindications to thrombolysis was present in 51% of our patients (n=499). The most common of these were age >80 years (n=159), mild stroke National Institutes of Health Stroke Scale score <5 (n=129), use of intravenous antihypertensives prior to treatment (n=112), symptom-to-needle time >3 hours (n=95), blood pressure >185/110 mm Hg (n=47), and oral anticoagulation (n=39). Age >80 years was the only contraindication independently associated with poor outcome (OR, 2.18; 95% CI, 1.27 to 3.73) in the multivariate model. None of the contraindications were associated with an increased risk of symptomatic intracerebral hemorrhage. Conclusions— Off-license thrombolysis was not associated with poorer clinical outcome, except for age >80 years, nor with increased rates of symptomatic intracerebral hemorrhage. The current extensive list of contraindications should be re-evaluated when data from ongoing randomized trials and observational studies become available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.109.576140

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 208

Metadata

Authors
Meretoja, A., Putaala, J., Tatlisumak, T., Atula, S., Artto, V., Curtze, S., Häppölä, O., Lindsberg, P. J., Mustanoja, S., Piironen, K., Pitkäniemi, J., Rantanen, K., Sairanen, T., Salonen, O., Silvennoinen, H., Soinne, L., Strbian, D., Tiainen, M., & Kaste, M.
Venue
Stroke
Published
2010-07
Volume
41
Issue
7
Pages
1450-1458
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2109783545
Cited by
208
References
2
FWCI
18.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke. https://app.cochat.ai/papers/10.1161/strokeaha.109.576140
The paper
Meretoja, A., Putaala, J., Tatlisumak, T., Atula, S., Artto, V., Curtze, S., Häppölä, O., Lindsberg, P. J., Mustanoja, S., Piironen, K., Pitkäniemi, J., Rantanen, K., Sairanen, T., Salonen, O., Silvennoinen, H., Soinne, L., Strbian, D., Tiainen, M., & Kaste, M. (2010). Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke. Stroke. https://doi.org/10.1161/strokeaha.109.576140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.